133 related articles for article (PubMed ID: 31580184)
21. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
[TBL] [Abstract][Full Text] [Related]
22. Dopamine D
Miyauchi M; Neugebauer NM; Meltzer HY
J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
[TBL] [Abstract][Full Text] [Related]
23. Prenatal administration of lipopolysaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brain.
Basta-Kaim A; Fijał K; Ślusarczyk J; Trojan E; Głombik K; Budziszewska B; Leśkiewicz M; Regulska M; Kubera M; Lasoń W; Wędzony K
Neuroscience; 2015 Feb; 287():78-92. PubMed ID: 25528062
[TBL] [Abstract][Full Text] [Related]
24. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
Osborne AL; Solowij N; Babic I; Lum JS; Huang XF; Newell KA; Weston-Green K
Brain Behav Immun; 2019 Oct; 81():574-587. PubMed ID: 31326506
[TBL] [Abstract][Full Text] [Related]
25. Trans-generation enrichment of clozapine-responsiveness trait in mice using a subchronic hypo-glutamatergic model of schizophrenia:A preliminary study.
Krivoy A; Gil-Ad I; Tarasenko I; Weizman A; Taler M
Behav Brain Res; 2017 Apr; 323():141-145. PubMed ID: 28167336
[TBL] [Abstract][Full Text] [Related]
26. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
[TBL] [Abstract][Full Text] [Related]
27. Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.
Nomura T; Oyamada Y; Fernandes HB; Remmers CL; Xu J; Meltzer HY; Contractor A
Neuropharmacology; 2016 Jan; 100():90-7. PubMed ID: 25937215
[TBL] [Abstract][Full Text] [Related]
28. Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.
Georgiev D; Yoshihara T; Kawabata R; Matsubara T; Tsubomoto M; Minabe Y; Lewis DA; Hashimoto T
Schizophr Bull; 2016 Jul; 42(4):992-1002. PubMed ID: 26980143
[TBL] [Abstract][Full Text] [Related]
29. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
[TBL] [Abstract][Full Text] [Related]
30. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wetchateng T; Sireeratawong S
J Med Assoc Thai; 2013 Feb; 96(2):231-8. PubMed ID: 23936991
[TBL] [Abstract][Full Text] [Related]
31. The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia.
Brown J; Iacovelli L; Di Cicco G; Grayson B; Rimmer L; Fletcher J; Neill JC; Wall MJ; Ngomba RT; Harte M
Neuropharmacology; 2022 May; 208():108982. PubMed ID: 35151699
[TBL] [Abstract][Full Text] [Related]
32. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
Castañé A; Santana N; Artigas F
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
[TBL] [Abstract][Full Text] [Related]
33. Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia.
Romón T; Mengod G; Adell A
Psychopharmacology (Berl); 2011 Sep; 217(2):231-8. PubMed ID: 21465242
[TBL] [Abstract][Full Text] [Related]
34. Sex differences in the adolescent developmental trajectory of parvalbumin interneurons in the hippocampus: a role for estradiol.
Wu YC; Du X; van den Buuse M; Hill RA
Psychoneuroendocrinology; 2014 Jul; 45():167-78. PubMed ID: 24845187
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDAR1 immunodensity in the prefrontal cortex, striatum and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S50-5. PubMed ID: 25518293
[TBL] [Abstract][Full Text] [Related]
36. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():204-12. PubMed ID: 26519556
[TBL] [Abstract][Full Text] [Related]
37. Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia.
Asif-Malik A; Dautan D; Young AMJ; Gerdjikov TV
Brain Struct Funct; 2017 Sep; 222(7):3179-3190. PubMed ID: 28293729
[TBL] [Abstract][Full Text] [Related]
38. Bacopa monnieri (Brahmi) Prevents Cognitive Deficit by Maintaining CA2/3 VGLUT1 Density of Sub-Chronic Phencyclidine Rat Model of Schizophrenia in Normal Level.
Piyabhan P; Wetchateng T
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S222-9. PubMed ID: 29926716
[TBL] [Abstract][Full Text] [Related]
39. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
40. Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory.
Doostdar N; Kim E; Grayson B; Harte MK; Neill JC; Vernon AC
J Psychopharmacol; 2019 Oct; 33(10):1274-1287. PubMed ID: 31060435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
